Literature DB >> 7188830

Within-day fluctuations in serum bile-acid concentrations among normal control subjects and patients with hepatic disease.

L R Engelking, C A Dasher, B I Hirschowitz.   

Abstract

Under carefully controlled conditions in a clinical research ward, conjugated primary bile-acid concentrations were measured by a 125I-radioimmunoassay every eight hours for four days in seven healthy control subjects and ten patients with hepatic disease (five with cirrhosis, three with primary biliary cirrhosis and two with sclerosing cholangitis). Two meals of approximately equal composition were consumed daily at 10 A.M. and 6 P.M., and blood was drawn at 4 A.M., 12 noon and 8 P.M.. With the exception of one patient, all subjects had greater postprandial than fasting serum bile-acid concentrations, with all healthy control subjects and most of those with hepatic disease showing evening values equal to or greater than the noon values. For the healthy control subjects, the mean values were 0.8, 1.4 and 1.9 microM, and for those with hepatic disease, 108, 140 and 133 microM. There were large fluctuations in serum bile acids (up to sevenfold) among patients with hepatic disease. These fluctuations were independently validated by finding corresponding changes in serum radioactivity derived from injection of a tracer (24-14C cholic acid) at the start of each study. To be consistent, especially for serial measurements, bile acids should be measured in blood taken at the same time of the day and at the same time relative to meals.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7188830     DOI: 10.1093/ajcp/73.2.196

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

1.  Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKD.

Authors:  Anna Jovanovich; Tamara Isakova; Geoffrey Block; Jason Stubbs; Gerard Smits; Michel Chonchol; Makoto Miyazaki
Journal:  Am J Kidney Dis       Date:  2017-08-09       Impact factor: 8.860

2.  Impact of exercise training on the sarcopenia criteria in non-alcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Andrea Gonzalez; Mayalen Valero-Breton; Camila Huerta-Salgado; Oscar Achiardi; Felipe Simon; Claudio Cabello-Verrugio
Journal:  Eur J Transl Myol       Date:  2021-03-26

Review 3.  Endocrine functions of bile acids.

Authors:  Sander M Houten; Mitsuhiro Watanabe; Johan Auwerx
Journal:  EMBO J       Date:  2006-03-16       Impact factor: 11.598

4.  Bile acid metabolites in serum: intraindividual variation and associations with coronary heart disease, metabolic syndrome and diabetes mellitus.

Authors:  Carine Steiner; Alaa Othman; Christoph H Saely; Philipp Rein; Heinz Drexel; Arnold von Eckardstein; Katharina M Rentsch
Journal:  PLoS One       Date:  2011-11-14       Impact factor: 3.240

Review 5.  Bile Acid Signaling Pathways from the Enterohepatic Circulation to the Central Nervous System.

Authors:  Kim L Mertens; Andries Kalsbeek; Maarten R Soeters; Hannah M Eggink
Journal:  Front Neurosci       Date:  2017-11-07       Impact factor: 4.677

6.  [Intrahepatic cholestasis of pregnancy].

Authors:  Carsten Hagenbeck; Ulrich Pecks; Frank Lammert; Matthi As C Hütten; Felix Borgmeier; Tanja Fehm; Ekkehard Schleußner; Holger Maul; Sven Kehl; Amr Hamza; Verena Keitel
Journal:  Gynakologe       Date:  2021-04-20

7.  Sarcopenia Induced by Chronic Liver Disease in Mice Requires the Expression of the Bile Acids Membrane Receptor TGR5.

Authors:  Johanna Abrigo; Fabián Campos; Francisco Gonzalez; Francisco Aguirre; Andrea Gonzalez; Camila Huerta-Salgado; Sabrina Conejeros; Felipe Simon; Marco Arrese; Daniel Cabrera; Alvaro A Elorza; Claudio Cabello-Verrugio
Journal:  Int J Mol Sci       Date:  2020-10-25       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.